Cite
HARVARD Citation
Dlouhy, I. et al. (n.d.). High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphoma. Leukemia research. pp. 20-25. [Online].